Headquartered in San Diego, California, Ferring Research Institute, Inc., (FRI) is a critical component of Ferring Pharmaceutical’s global therapeutics research and discovery engine.
Established in 1996, FRI is located in the heart of the Southern California biopharmaceutical community. The center has attracted a diverse group of highly skilled professionals representing over twenty four countries of origin.
FRI is focused on the following key therapeutic areas: reproductive health, urology, and gastroenterology. Our state-of-the art facility includes peptide and protein drug design, chemistry, pharmacology, biology, and preclinical ADME capabilities.
Historically FRI has focused on the discovery of amino acid-based therapeutics utilizing the body’s signaling hormones. Today FRI is committed to building a portfolio of novel, innovative therapeutics using a wide array of modalities in order to address areas of high unmet medical need in our core therapeutic areas. Driving value through personalized medicine.
The Ferring Research Institute, Inc., moved to its new home in San Diego in February 2009 with the opening of a 38,000-square-foot facility in Sorrento Valley. The new state-of-the art facility research houses expanded research laboratories for peptide medicinal chemistry, biochemistry, bioanalytical, and pharmacology.
The small group of researchers working in San Diego has now grown to a staff of more than 80.